Lois A. Bowers

Lois has spent almost her entire career covering healthcare, the business of healthcare and related topics via journalism or public relations. She holds a master's degree in journalism and mass communication from Kent State University and is the recipient of the Jesse H. Neal National Business Journalism Award as well as other honors.

All articles by Lois A. Bowers

Evidence-Based Medicine

Apixaban in Patients With ESRD and Atrial Fibrillation

Alan Ehrlich, MD

January 30, 2019

There are limited published data on the efficacy and safety of direct-acting oral anticoagulants (DOACs) in patients with end-stage renal disease (ESRD) on dialysis and atrial fibrillation.

Evidence-Based Medicine

Assessment of Dual Antiplatelet Therapy After Stroke, TIA

Alan Ehrlich, MD

January 30, 2019

Questions about the generalizability of previous data on dual antiplatelet therapy after minor ischemic stroke or high-risk transient ischemic attack lead investigators of the POINT trial to conduct a similar study in an international population.

Evidence-Based Medicine

Albiglutide Reduces Major CV Events in Patients With Type II Diabetes and Known CVD

Alan Ehrlich, MD

January 30, 2019

Albiglutide is available in other countries, and this trial may serve as an impetus for its reintroduction in the United States, particularly if follow-up results show a survival advantage with albiglutide.

Evidence-Based Medicine

Physical Therapy May Allow Patients With Meniscal Tears to Avoid Surgery

Alan Ehrlich, MD

January 30, 2019

Starting with physical therapy and having surgery only if that failed was as effective as immediate surgery in patients with osteoarthritis of the knee.

Evidence-Based Medicine

Emollient Bath Additives Ineffective for Atopic Dermatitis in Children

Alan Ehrlich, MD

September 7, 2018

Although the American Academy of Dermatology recommends the direct application of emollients to the skin in patients with atopic dermatitis, the addition of oils, emollients, or other additives to bath water is not recommended due to insufficient evidence regarding their efficacy.

Evidence-Based Medicine

Adjuvant Chemo With Endocrine Therapy for HR+/HER2- Breast Cancer

Alan Ehrlich, MD

September 6, 2018

Although endocrine therapy following surgery is recommended for HR-positive/HER2-negative, axillary node-negative breast cancers, the value of adjuvant chemotherapy in the setting of moderate risk is unclear.

Evidence-Based Medicine

Limited Formula Supplementation May Not Adversely Affect Breastfeeding

Alan Ehrlich, MD

August 30, 2018

Although exclusive breastfeeding for the first 6 months of life is recommended by several health organizations, there may be a delay before abundant maternal milk production is established.

Evidence-Based Medicine

Budesonide/Formoterol for the Prevention of Serious Asthma Exacerbations

Alan Ehrlich, MD

August 30, 2018

The SYGMA trials assessed the use of an as-needed combined corticosteroid/beta-agonist inhaler in patients with mild asthma.

Evidence-Based Medicine

Antenatal steroids may improve respiratory outcomes for late preterm births

Alan Ehrlich, MD

February 1, 2017

The decreased rate of respiratory complications with betamethasone suggests antenatal steroids may improve the respiratory status in late preterm infants.

Proton pump inhibitors associated with increased risk of dementia in elderly.

Evidence-Based Medicine

Regular proton pump inhibitor use associated with an increased risk of dementia in the elderly

Alan Ehrlich, MD

February 1, 2017

Regular proton pump inhibitor use in the elderly was associated with an increased risk of incident dementia compared with no proton pump inhibitor use, according to researchers.

Next post in Evidence-Based Medicine